Ozalin (Midazolam)

Midazolam, the active ingredient in Ozalin, is a benzodiazepine presented as a strength/form for parenteral use. It is used for sedation, anxiolysis, and seizure control in hospital settings. GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

The    

Midazolam may exhibit several adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness - Dizziness - Light‑headed   - Respiratory   - Hypotension   - Nausea

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Paradoxical agitation or aggression   - Anaphylactic reaction   - Cardiac arrhythmia  

Midazolam requires careful monitoring throughout its use.

- Patient assessment: assess   g    t   ewline   ewline -    ewline  \n-       ewline  ewline  \